BioAtla BCAB
OTC BCAB
$1.35 -0.15 (-10.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

BioAtla (BCAB) Other Operating Expenses (2020 - 2026)

Updated

BioAtla's Other Operating Expenses came in at $11,000 for Q2 2026, down 45.0% from the prior quarter.

Analysis

BioAtla (BCAB) Other Operating Expenses (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, BioAtla reported Other Operating Expenses of $34,000, up 325.0% year-over-year.

  • The five-year range for quarterly Other Operating Expenses is $3,000 (Q3 2025) to $20,000 (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 BioAtla 2.25 Mn 2.25 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11,000.00
Mar 31, 2026 20,000.00
Sep 30, 2025 3,000.00
Sep 30, 2024 8,000.00
Mar 31, 2020 -926,000.00
API Access

BioAtla Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=BCAB&period=max&api_key=YOUR_API_KEY